We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Safety, Effectiveness and Patient Acceptance of the Treatment With MabCampath in Chronic Lymphocytic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00836043
Recruitment Status : Terminated (Study terminated due to low enrollment.)
First Posted : February 4, 2009
Last Update Posted : December 3, 2013
Information provided by (Responsible Party):
Sanofi ( Genzyme, a Sanofi Company )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : April 2009
  Study Completion Date : April 2009